Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study

Journal of Headache and Pain

Volumn 16, Issue 1, 2015, Pages

  Wu, Tung Han ^b   Hu, Li Yu ^a,c   Lu, Ti ^a   Chen, Pan Ming ^d   Chen, Hon Jhe ^a   Shen, Cheng Che ^b,c,e   Wen, Chun Hsien ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Anxiety disorder; Depressive disorder; Retrospective cohort study; Sleep disorder; Trigeminal neuralgia

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SLEEP DISORDER; TRIGEMINUS NEURALGIA; YOUNG ADULT; AGED; ANXIETY DISORDERS; COMPLICATION; DEPRESSIVE DISORDER; FACTUAL DATABASE; HEALTH SURVEY; MENTAL DISORDERS; PROCEDURES; PSYCHOLOGY; RISK FACTOR; SLEEP WAKE DISORDERS; TAIWAN; TRIGEMINAL NEURALGIA;

ADULT; AGED; ANXIETY DISORDERS; COHORT STUDIES; DATABASES, FACTUAL; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SLEEP WAKE DISORDERS; TAIWAN; TRIGEMINAL NEURALGIA;

EID: 84937869423     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1186/s10194-015-0548-y     Document Type: Article

References (62)

1. Obermann M, Yoon MS, Ese D, Maschke M, Kaube H, Diener HC, Katsarava Z (2007) Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 69(9):835–841. doi:10.1212/01.wnl.0000269670.30045.6b
2. Obermann M, Holle D, Katsarava Z (2011) Trigeminal neuralgia and persistent idiopathic facial pain. Expert Rev Neurother 11(11):1619–1629. doi:10.1586/ern.11.156
3. The International Classification of Headache Disorders (2013) 3rd edition (beta version). Cephalalgia: Int J Headache 33(9):629–808. doi:10.1177/0333102413485658
4. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT (1991) Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945–1984. Neuroepidemiology 10(5–6):276–281
5. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD (2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain: J Neurol 123(Pt 4):665–676
6. Katusic S, Beard CM, Bergstralh E, Kurland LT (1990) Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol 27(1):89–95. doi:10.1002/ana.410270114
7. Cruccu G, Iannetti GD, Marx JJ, Thoemke F, Truini A, Fitzek S, Galeotti F, Urban PP, Romaniello A, Stoeter P, Manfredi M, Hopf HC (2005) Brainstem reflex circuits revisited. Brain: J Neurol 128(Pt 2):386–394. doi:10.1093/brain/awh366
8. Herweh C, Kress B, Rasche D, Tronnier V, Troger J, Sartor K, Stippich C (2007) Loss of anisotropy in trigeminal neuralgia revealed by diffusion tensor imaging. Neurology 68(10):776–778. doi:10.1212/01.wnl.0000256340.16766.1d
9. Cruccu G, Biasiotta A, Di Rezze S, Fiorelli M, Galeotti F, Innocenti P, Mameli S, Millefiorini E, Truini A (2009) Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143(3):186–191. doi:10.1016/j.pain.2008.12.026
10. Jia DZ, Li G (2010) Bioresonance hypothesis: a new mechanism on the pathogenesis of trigeminal neuralgia. Med Hypotheses 74(3):505–507. doi:10.1016/j.mehy.2009.09.056
11. Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P (2010) Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat 6:81–91
12. Puca F, Headaches ICGftSoPFiP (2000) Psychological and social stressors and psychiatric comorbidity in patients with migraine without aura from headache centers in Italy: a comparison with tension-type headache patients. J Headache Pain 1(1):17–25
13. Smitherman TA, Baskin SM (2008) Headache secondary to psychiatric disorders. Curr Pain Headache Rep 12(4):305–310
14. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54(2):308–313
15. Zakrzewska JM (2013) Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain 14(1):37. doi:10.1186/1129-2377-14-37
16. Hals EKB, Stubhaug A (2011) Mental and somatic co-morbidities in chronic orofacial pain conditions: Pain patients in need of multiprofessional team approach. Scandinavian J Pain 2(4):153–154. doi:10.1016/j.sjpain.2011.08.003
17. Devor M, Wood I, Sharav Y, Zakrzewska JM (2008) Trigeminal neuralgia during sleep. Pain practice: the official journal of World Institute of Pain 8(4):263–268. doi:10.1111/j.1533-2500.2008.00214.x
18. Sabalys G, Juodzbalys G, Wang HL (2013) Aetiology and pathogenesis of trigeminal neuralgia: a comprehensive review. J Oral Maxillofac Res 3(4), e2. doi:10.5037/jomr.2012.3402
19. Sawaya RA (2000) Trigeminal neuralgia associated with sinusitis. ORL J Otorhinolaryngol Relat Spec 62(3):160–163.
20. Lin YW, Lin SK, Weng IH (2006) Fatal paranasal sinusitis presenting as trigeminal neuralgia. Headache 46(1):174–178. doi:10.1111/j.1526-4610.2006.00316_5.x
21. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7(1):41–53. doi:10.1038/nrn1824
22. Lampa J, Westman M, Kadetoff D, Agreus AN, Le Maitre E, Gillis-Haegerstrand C, Andersson M, Khademi M, Corr M, Christianson CA, Delaney A, Yaksh TL, Kosek E, Svensson CI (2012) Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci U S A 109(31):12728–12733. doi:10.1073/pnas.1118748109
23. Leza JC, Bueno BG, Bioque M, Arango C, Parellada M, Do K, O’Donnell P, Bernardo M (2015) Inflammation in schizophrenia: A question of balance. Neurosci Biobehav Rev. doi:10.1016/j.neubiorev.2015.05.014
24. Patel JP, Frey BN (2015) Disruption in the Blood–brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? Neural Plast 2015:708306. doi:10.1155/2015/708306
25. Rudich Z, Lerman SF, Gurevich B, Shahar G (2010) Pain specialists’ evaluation of patient’s prognosis during the first visit predicts subsequent depression and the affective dimension of pain. Pain Med (Malden, Mass) 11(3):446–452. doi:10.1111/j.1526-4637.2009.00795.x
26. Meskal I, Rutten GJ, Beute GN, Salden ME, Sitskoorn MM (2014) Cognitive deficits in patients with trigeminal neuralgia: opportunities to improve care and quality of life. Acta Neurochir 156(8):1565–1566. doi:10.1007/s00701-014-2100-2
27. Hart RP, Martelli MF, Zasler ND (2000) Chronic pain and neuropsychological functioning. Neuropsychol Rev 10(3):131–149
28. Hart RP, Wade JB, Martelli MF (2003) Cognitive impairment in patients with chronic pain: the significance of stress. Curr Pain Headache Rep 7(2):116–126
29. Moriarty O, McGuire BE, Finn DP (2011) The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 93(3):385–404. doi:10.1016/j.pneurobio.2011.01.002
30. Cavanna AE, Ali F, Rickards HE, McCorry D (2010) Behavioral and cognitive effects of anti-epileptic drugs. Discov Med 9(45):138–44 (1944-7930 (Electronic))
31. Mitolo M, Venneri A, Wilkinson ID, Sharrack B (2015) Cognitive rehabilitation in multiple sclerosis: A systematic review. J Neurol Sci 354(1–2):1–9. doi:10.1016/j.jns.2015.05.004
32. Tolle T, Dukes E, Sadosky A (2006) Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain practice: the official journal of World Institute of Pain 6(3):153–160. doi:10.1111/j.1533-2500.2006.00079.x
33. Mitchell AJ, Kemp S, Benito-León J, Reuber M (2010) The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatr 22(1):2–13. doi:10.1111/j.1601-5215.2009.00439.x
34. He CH, Yu F, Jiang ZC, Wang JY, Luo F (2014) Fearful thinking predicts hypervigilance towards pain-related stimuli in patients with chronic pain. PsyCh J 3(3):189–200. doi:10.1002/pchj.57
35. Lin FC, Tsai CP, Kuang-Wu Lee J, Wu MT, Tzu-Chi Lee C (2015) Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case–control study. JAMA Neurol 72(1):40–48. doi:10.1001/jamaneurol.2014.3367
36. Wang YP, Chen YT, Tsai CF, Li SY, Luo JC, Wang SJ, Tang CH, Liu CJ, Lin HC, Lee FY, Chang FY, Lu CL (2014) Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry 171(1):54–61. doi:10.1176/appi.ajp.2013.12111467
37. Arap A, Siqueira SR, Silva CB, Teixeira MJ, Siqueira JT (2010) Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol 55(7):486–493. doi:10.1016/j.archoralbio.2010.03.021
38. Pan SL, Yen MF, Chiu YH, Chen LS, Chen HH (2011) Increased risk of trigeminal neuralgia after hypertension: a population-based study. Neurology 77(17):1605–1610. doi:10.1212/WNL.0b013e3182343354
39. Teruel A, Ram S, Kumar SK, Hariri S, Clark GT (2009) Prevalence of hypertension in patients with trigeminal neuralgia. J Headache Pain 10(3):199–201. doi:10.1007/s10194-009-0107-5
40. El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Abdel Hakeem MN, Badry R, Kandil MR (2013) Prevalence of trigeminal neuralgia in Al-Quseir city (Red sea Governorate), Egypt. Clin Neurol Neurosurg 115(9):1792–1794. doi:10.1016/j.clineuro.2013.04.014
41. Duransoy YK, Mete M, Akcay E, Selcuki M (2013) Differences in individual susceptibility affect the development of trigeminal neuralgia. Neural Regen Res 8(14):1337–1342. doi:10.3969/j.issn.1673-5374.2013.14.010
42. Bendtsen L, Birk S, Kasch H, Aegidius K, Sorensen PS, Thomsen LL, Poulsen L, Rasmussen MJ, Kruuse C, Jensen R (2012) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition. J Headache Pain 13(Suppl 1):S1–29. doi:10.1007/s10194-011-0402-9
43. Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34. doi:10.1186/1129-2377-15-34
44. Rahman T, Campbell A, O'Connell CR, Nallapula K (2014) Carbamazepine in bipolar disorder with pain: reviewing treatment guidelines. The primary care companion for CNS disorders 16 (5). doi:10.4088/PCC.14r01672
45. Smith JG, Elias LA, Yilmaz Z, Barker S, Shah K, Shah S, Renton T (2013) The psychosocial and affective burden of posttraumatic neuropathy following injuries to the trigeminal nerve. J Orofac Pain 27(4):293–303. doi:10.11607/jop.1056
46. Macianskyte D, Januzis G, Kubilius R, Adomaitiene V, Sciupokas A (2011) Associations between chronic pain and depressive symptoms in patients with trigeminal neuralgia. Medicina (Kaunas, Lithuania) 47(7):386–392
47. Blier P, Abbott FV (2001) Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry & Neurosci: JPN 26(1):37–43
48. Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M (2008) An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochem Int 52(4–5):701–708. doi:10.1016/j.neuint.2007.08.021
49. Strittmatter M, Grauer M, Isenberg E, Hamann G, Fischer C, Hoffmann KH, Blaes F, Schimrigk K (1997) Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache 37(4):211–216
50. Gold PW (2015) The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry 20(1):32–47. doi:10.1038/mp.2014.163
51. Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157(5):683–694
52. Devor M, Amir R, Rappaport ZH (2002) Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 18(1):4–13
53. Devor M, Govrin-Lippmann R, Rappaport ZH (2002) Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 96(3):532–543. doi:10.3171/jns.2002.96.3.0532
54. Angulo MC, Kozlov AS, Charpak S, Audinat E (2004) Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J Neurosci: J Soc Neurosci 24(31):6920–6927. doi:10.1523/jneurosci.0473-04.2004
55. Molina LA, Skelin I, Gruber AJ (2014) Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex. PLoS One 9(1), e85842. doi:10.1371/journal.pone.0085842
56. Iwata K, Imamura Y, Honda K, Shinoda M (2011) Physiological mechanisms of neuropathic pain: the orofacial region. Int Rev Neurobiol 97:227–250. doi:10.1016/b978-0-12-385198-7.00009-6
57. Sessle BJ (2011) Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 97:179–206. doi:10.1016/b978-0-12-385198-7.00007-2
58. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56(11):1043–1047
59. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC (2007) Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64(2):193–200. doi:10.1001/archpsyc.64.2.193
60. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351–354
61. Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Flood P, Simpson HB (2013) Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 38(12):2475–2483. doi:10.1038/npp.2013.150
62. Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71(6):681–688. doi:10.1001/jamapsychiatry.2014.62